At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 34 enrolled
Drug / intervention
terbutaline sulphate delivered dose +1 moredrug
Likely dose
terbutaline sulphate delivered dose 0.4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-label, Single-dose, 2-period Cross Over Study in Healthy Volunteers to Assess Relative Bioavailability of Terbutaline Sulphate 1.5 mg After Inhalation Via the M3 Turbuhaler Compared With the M2 Turbuhaler
In Brief
A Phase 1 clinical trial evaluating terbutaline sulphate delivered dose and terbutaline sulphate metered dose for Healthy Volunteers. Completed, enrolled 34 participants across 1 site.
Detailed Summary
Relative bioavailability study to compare inhalation of Terbutaline Sulphate 1,5mg via current version of Turbuhaler with inhalation via a new version
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartAug 2014
Primary CompletionNov 2014
TodayJul 2026
First PostedJun 30, 2014
Enrollment StartAug 1, 2014
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 12.0 years ago
Interventions
terbutaline sulphate delivered dosedrug
0.4 mg terbutaline sulphate (delivered dose) per inhalation
terbutaline sulphate metered dosedrug
0.5 mg terbutaline sulphate (metered dose) per inhalation